Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Color change
BEACON CRC (binimetinib [BINI], encorafenib [ENCO], and cetuximab [CTX] combined to treat BRAF-mutant metastatic colorectal cancer [mCRC]): A multicenter, randomized, open-label, three-arm phase III study of ENCO plus CTX plus or minus BINI vs irinotecan (IRI)/CTX or infusional 5-fluorouracil/folinic acid/IRI (FOLFIRI)/CTX with a safety lead-in of ENCO + BINI + CTX in patients (Pts) with BRAFV600E mCRC
Our qualified US Licensed Providers prioritize your well-being, providing top-quality care
Psychosis secondary to thyrotoxicosis: an educational review
Anabolic Signaling IGF-1 LR3 activates the same cellular pathways as natural IGF-1 , stimulating protein synthesis, promoting cellular proliferation, and enhancing nutrient uptake in muscle and other tissues
At Perfect B, we tell patients to plan for this
US$ 28.60
US$ 20.80
US$ 20.64
US$ 20.22
US$ 26.16
US$ 22.90
